Atsushi Matsuda

Title: Atsushi Matsuda: Innovator in T-Cell Receptor Technology

Introduction

Atsushi Matsuda is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of immunology. His work primarily focuses on T-cell receptors, which play a crucial role in the immune response against cancer.

Latest Patents

Matsuda holds a patent for a T-cell receptor that is capable of binding to specific peptides. This receptor can bind to a peptide with the amino acid sequence shown in SEQ ID NO: 27 or a complex of the peptide and HLA-A24. Additionally, it can bind to a peptide with the amino acid sequence shown in SEQ ID NO: 28 or a complex of the peptide and HLA-A02. The disclosed T-cell receptors are particularly useful in treating or preventing cancers associated with the expression of glypican-3. He has 1 patent to his name.

Career Highlights

Throughout his career, Matsuda has worked with esteemed institutions such as the National Cancer Center Japan and Kyoto University. His research has significantly advanced the understanding of T-cell receptor functionality and its applications in cancer therapy.

Collaborations

Matsuda has collaborated with notable colleagues, including Tetsuya Nakatsura and Toshiaki Yoshikawa, contributing to various research projects that aim to enhance cancer treatment methodologies.

Conclusion

Atsushi Matsuda's innovative work in T-cell receptor technology exemplifies the potential of scientific research in combating cancer. His contributions continue to inspire advancements in immunotherapy and cancer treatment strategies.